Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
Testicular Germ Cell Tumor Incidence Increased for All Races/Ethnicities
Greatest increase in incidence between 2001 to 2016 seen for Asian/Pacific Islanders, followed by Hispanics
UGN-101 Active in Chemoablation of Upper Tract Urothelial Cancer
Fifty-nine percent of patients had complete response at four to six weeks after initial therapy
Link Found Between Body Size in Childhood, Later Life Disease
Larger genetically predicted body size in childhood link to later CAD, T2DM due to large adult body size
Anticoagulation May Improve Outcomes in COVID-19 Patients
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
Health Insurance Coverage Disruption Impedes Cancer Care
Findings consistent across cancer continuum, from screening to treatment and end-of-life care
Guidance Developed for Lung Cancer Screening During COVID-19
Consensus statement covers lung cancer screening and monitoring, evaluation, management of lung nodules
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials
Whole-Body DW MRI Can Help Assess Pediatric Tumor Response
Good agreement for treatment response assessments with DW MRI, FDG PET seen in children, young adults
Genomically Targeted Treatment Slows Advanced Prostate Cancer
Men receiving olaparib versus standard treatment experience delayed disease progression
